5 research outputs found
Kaplan-meier survival curve comparing patients with RVEF < 35% (n = 48) and RVEF≥ 35% (n = 61) undergoing CABG or valve procedures.
<p>The top curve corresponds to patients with RVEF <35% and the bottom curve to patients with RVEF≥ 35%. The number below each year indicates the number of patients at risk.</p
Patient Characteristics.
<p>Cerebral vascular accident, CVA, Pro-BNP, pro-brain natriuretic peptide; LDL, low-density lipoprotein; HDL, high density lipoprotein; RVEF, right ventricular ejection fraction; RVSP, right ventricular systolic pressure; mPAP, mean pulmonary artery pressure; LVEF, left ventricular ejection fraction. Measurements of RV and LV volumes, mass, regional wall motion abnormalities, and function were obtained by CMR; TR and PAP by echocardiography.</p><p>Patient Characteristics.</p
Analysis of early (≤ 30-d) and long-term (> 30-d) outcomes associated with RVEF <35% and RVEF ≥ 35%.
<p>ICU, intensive care unit; IQR, interquartile range; LFT, liver function test; postoperative complications (i.e. reoperations for bleeding, early valve reoperations, deep sternal infection, early stroke, early transient ischemic attack, pacemaker implantation, myocardial infarction, atrial fibrillation and renal insufficiency requiring dialysis).</p><p>Analysis of early (≤ 30-d) and long-term (> 30-d) outcomes associated with RVEF <35% and RVEF ≥ 35%.</p
Preoperative CMR.
<p>Short axis cine views traced right ventricle (A), left ventricle (B) and right ventricle from base to the apex (C) for ejection fraction measurements. Marked region of interest is demonstrated in green.</p
Analysis of early (≤ 30-d) and long-term (> 30-d) outcomes associated with primary CABG and valve procedures.
<p>Early complications within 30-d include reoperations for bleeding, early valve reoperations, deep sternal infection, early stroke, early transient ischemic attack, pacemaker implantation, myocardial infarction, atrial fibrillation, and renal insufficiency requiring dialysis.</p><p>Analysis of early (≤ 30-d) and long-term (> 30-d) outcomes associated with primary CABG and valve procedures.</p